Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 14;51(2):287-289.
doi: 10.1093/schbul/sbae227.

Response to Commentaries

William P Horan  1   2 , Amir Kalali  3 , Stephen K Brannan  4 , Wayne Drevets  4 , Atul Mahableshwarkar  5 , Srinivas Rao  6 , Corey Reuteman-Fowler  7 , Adam Savitz  8 , Jaskaran Singh  9 , Gary Walker  10 , Jens R Wendland  11 , Philip D Harvey  12
Affiliations

Response to Commentaries

William P Horan et al. Schizophr Bull. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr Horan is an employee of Karuna Therapeutics, A Bristol Myers Squibb company. Dr Kalali is Founder and Executive Secretary of the International Society for CNS Drug Development and on the Board of Directors at atai Life Sciences. Dr Brannan is on the board or a consultant to BMS, Kynexis, Seaport Therapeutics, and EMA-Wellness. Dr Drevets is an employee of and equity holder in Janssen Research and Development, LLC, a Johnson & Johnson company. Dr Mahableshwarkar is an employee of Cybin IRL and owns stock in J&J, Emalex Biosciences, and Cybin IRL. Dr Rao is an employee of atai Life Sciences. Dr Reuteman-Fowler is an employee of Boehringer Ingelheim. Dr Savitz is an employee of Alto Neuroscience and holds equity in Alto Neuroscience and Johnson & Johnson. Dr Singh is an employee of Neurocrine Biosciences. Dr Walker is an employee and equity holder in Recognify Life Sciences. Dr Wendland is an employee and stock option holder of Kynexis Therapeutics and a former employee and current stockholder of Takeda Pharmaceuticals. Dr Harvey is a consultant for Alkermes, Boehringer-Ingelheim, Bristol Myers Squibb, Merck, Minerva Neuroscience, and Sunovion/DSP and has received royalties from WCG.

References

    1. Horan WP, Moore RC, Belanger HG, Harvey PD.. Utilizing technology to enhance the ecological validity of cognitive and functional assessments in schizophrenia: an overview of the state-of-the-art. Schizophr Bull Open. 2024;5:sgae025. https://doi.org/10.1093/schizbullopen/sgae025 - DOI - PMC - PubMed
    1. Feber L, Peter NL, Chiocchia V, et al.Antipsychotic drugs and cognitive function: a systematic review and pairwise network meta-analysis. JAMA Psychiatry. 2025;82:47–56. https://doi.org/10.1001/jamapsychiatry.2024.2890 - DOI - PMC - PubMed
    1. Accessed December 12, 2024. https://www.fda.gov/drugs/news-events-human-drugs/evaluating-negative-sy...